Regenerative Medical Technology (RMTG) EBITDA Margin (QoQ) (2018 - 2026)
Powered by 
Analysis
Regenerative Medical Technology (RMTG) EBITDA Margin (QoQ) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.42 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.36 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Regenerative Medical Technology | 1.12 Mn | -199,206.02 | 2.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 424.00 |
| Mar 31, 2026 | 2,626.00 |
| Dec 31, 2025 | 1,860.00 |
| Sep 30, 2025 | -1,104.00 |
| Jun 30, 2025 | -3,424.00 |
| Mar 31, 2025 | -984.00 |
| Dec 31, 2024 | 1,321.00 |
| Sep 30, 2024 | 2,811.00 |
| Jun 30, 2024 | -1,311.00 |
| Mar 31, 2024 | 369.00 |
| Dec 31, 2023 | -1,381.00 |
| Sep 30, 2023 | 10,686.00 |
| Jun 30, 2023 | -9,787.00 |
| Mar 31, 2023 | 43,678.00 |
| Dec 31, 2022 | -40,894.00 |
| Sep 30, 2022 | 7,791.00 |
| Jun 30, 2022 | 6,151.00 |
| Mar 31, 2022 | 1,339.00 |
| Dec 31, 2021 | 526,866.00 |
| Sep 30, 2021 | -384,192.00 |